At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 28 enrolled
Drug / intervention
Nurofen for Children® +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Single-dose, 4-way Crossover, Open-label, Pharmacokinetic (PK) Study Comparing a 2% (w/v) Suspension of Ibuprofen (400 mg/20 mL Nurofen for Children®) With a Swiss Reference 2% (w/v) Suspension of Ibuprofen (400 mg/20 mL Algifor Dolo Junior®) in the Fed and Fasted States
In Brief
A Phase 1 clinical trial evaluating Nurofen for Children® and Algifor Dolo Junior® for Healthy Volunteer Study. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The purpose of this study was to determine the rate and extent of absorption of Ibuprofen suspension formulations.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteer Study
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedJul 2015
Primary CompletionAug 2015
TodayJul 2026
First PostedJul 20, 2015
Enrollment StartJun 2, 2015
Primary CompletionAug 25, 2015
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 11.0 years ago
Interventions
Nurofen for Children®drug
Algifor Dolo Junior®drug